UBS Lux Equity Fund Biotech USD vs SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist

UBS Lux Equity Fund Biotech USD vs SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    5

2. SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist

  • Security

    SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist

  • Fee

    0.55%

  • ISIN

    IE00B6YX5B26

  • Holdings

    10

Fund Holdings

We have information about 7 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Gilead Sciences (4.66). In comparison with SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist, we have 11 holdings where Chailease Holding is the largest holding (7.49), followed by Vanguard International Semiconductor (5.99) and KT&G (5.44).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist.

UBS Lux Equity Fund Biotech USD SPDR S&P Emerging Markets Dividend Aristocrats UCITS ETF Dist
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Chailease Holding Co Ltd
Taiwan
7.49 %
2. Moderna Inc
9.21 %
2. Vanguard International Semiconductor Corp
Taiwan
5.99 %
3. Gilead Sciences Inc
USA
4.66 %
3. KT&G Corp
South Korea
5.44 %
4. BioNTech SE
4.13 %
4. Saudi Telecom Co
Saudi Arabia
5.27 %
5. Karuna Therapeutics Inc
3.75 %
5. Telkom Indonesia Persero ADR
Indonesia
4.34 %
- 6. Radiant Opto-Electronics Corp
Taiwan
3.43 %
- 7. Emirates NBD Bank PJSC
United Arab Emirates
3.36 %
- 8. Bosideng International Holdings Ltd
China
3.1 %
- 9. Sinbon Electronics Co Ltd
China
2.62 %
- 10. Emirates Telecommunications Group Co PJSC
United Arab Emirates
2.42 %

The list of fund holdings was last updated on September 10, 2025.